Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.82 | ||
| Change(%) | ![]() | +0.01 | |
| Volume | 266286 | ||
| 1:26 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
UCB"s Cimzia® Approved in the U.S. for Adult Patients Suffering from Moderate to Severe Rheumatoid Arthritis
-- Enzon to receive royalties for PEGylation technology--
Enzon Pharmaceuticals Commences Tender Offer For a Portion of its Debt

Enzon to Release Fourth Quarter 2008 Earnings on Thursday, February 19, 2009; Conference Call and Webcast to Follow
Cimzia®, Utilizing Enzon's PEGylation Technology, Approved in the U.S.
Enzon's New Oncaspar-IV™ Receives Orphan Drug Status in the EU
-- Improved version to expand global potential --
Enzon Files For Spin-Off of Biotech Business
